Position in MYGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$203,071
+$106,572 QoQ
Shares Held
45,127
+187.6% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026AXQ CAPITAL, LP holds $11,683,566 across 11 Diagnostics & Research names. MYGN ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,409 | $3,150,215 | |
| 2 | DHR |
Danaher Corp /De/
|
10,354 | $1,963,118 | |
| 3 | A |
Agilent Technologies, Inc.
|
16,042 | $1,828,467 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
2,960 | $1,663,194 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
1,098 | $1,384,797 | |
| 6 | QGEN |
Qiagen N.V.
|
23,227 | $930,009 | |
| 7 | GRAL |
GRAIL, Inc.
|
6,609 | $341,553 | |
| 8 | MYGN |
Myriad Genetics Inc
This page
|
45,127 | $203,071 |
All Filings in MYGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $203,071 | 45,127 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $96,499 | 15,691 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $82,769 | 11,448 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||